Alopecia Areata: Unseen Burdens and Unmet Needs – Comment on ‘The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy’

Alopecia areata (AA) imposes a complex, multidimensional burden that extends far beyond visible hair loss, with psychosocial distress often shaped more by individual perceptions and stigma than disease severity. Treatment success should prioritise patient-reported outcomes, including psychological wellbeing and social functioning, rather than focusing solely on hair regrowth. While advances such as JAK inhibitors have improved clinical and quality-of-life outcomes, significant inequities in access to both medical and supportive therapies persist, limiting optimal care. Additionally, the substantial and often overlooked financial burden of AA underscores the need for more equitable healthcare policies and cost-effective treatment strategies.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Dermatology
Published
2026-04-14
DOI
https://doi.org/10.1093/ced/llag177
Primary Topic
Hair Growth and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alopecia Areata: Unseen Burdens and Unmet Needs – Comment on ‘The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy’

Yasmin Nikookam, Aparna Potluru
Clinical and Experimental Dermatology
Hair Growth and Disorders
article

Alopecia Areata: Unseen Burdens and Unmet Needs – Comment on ‘The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy’

Yasmin Nikookam, Aparna Potluru
article en

Abstract

Alopecia areata (AA) imposes a complex, multidimensional burden that extends far beyond visible hair loss, with psychosocial distress often shaped more by individual perceptions and stigma than disease severity. Treatment success should prioritise patient-reported outcomes, including psychological wellbeing and social functioning, rather than focusing solely on hair regrowth. While advances such as JAK inhibitors have improved clinical and quality-of-life outcomes, significant inequities in access to both medical and supportive therapies persist, limiting optimal care. Additionally, the substantial and often overlooked financial burden of AA underscores the need for more equitable healthcare policies and cost-effective treatment strategies.

Clinical and Experimental Dermatology
NHS Greater Glasgow and Clyde (GB), Royal Hospital for Children (GB), St George’s University Hospitals NHS Foundation Trust (GB)
Openalex Percentile: Top 19%
Hair Growth and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.